Effect of atenolol and labetalol on serum lipids.

Abstract

Adverse alterations in lipid profile suggesting higher atherogenicity were observed following 12 weeks treatment with atenolol in patients of hypertension. No significant alterations in lipid profile were observed with labetalol therapy. 

Topics

  • Presentations referencing similar topics